BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Oct 08, 2012
 |  BC Extra  |  Company News

Sanofi purchases $70M of Genzyme CVRs

Sanofi (Euronext:SAN; NYSE:SNY) paid $70 million to purchase 40 million of the outstanding Genzyme Corp. contingent value rights at $1.75 per right in a modified Dutch auction tender offer. The price is...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >